KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $48.0 million.

  • Medtronic's Net Cash Flow fell 3924.05% to $48.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$293.0 million, marking a year-over-year decrease of 55781.25%. This contributed to the annual value of $746.0 million for FY2025, which is 267241.38% up from last year.
  • As of Q4 2025, Medtronic's Net Cash Flow stood at $48.0 million, which was down 3924.05% from -$1.0 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Net Cash Flow ranged from a high of $2.8 billion in Q4 2022 and a low of -$2.9 billion during Q2 2023
  • Moreover, its 5-year median value for Net Cash Flow was -$59.5 million (2021), whereas its average is -$259.5 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 303684.21% in 2022, then plummeted by 2520000.0% in 2025.
  • Medtronic's Net Cash Flow (Quarter) stood at -$95.0 million in 2021, then surged by 3036.84% to $2.8 billion in 2022, then tumbled by 94.73% to $147.0 million in 2023, then plummeted by 46.26% to $79.0 million in 2024, then tumbled by 39.24% to $48.0 million in 2025.
  • Its last three reported values are $48.0 million in Q4 2025, -$1.0 billion for Q3 2025, and $695.0 million during Q2 2025.